Nina Vasan, MD
Psychiatry · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 4
- 1 carrier
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Vasan’s office at (304) 615-8037 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A134117 · Current
Licensed to practise in California · since 2015 · expires 2027-01-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 30 Part D prescriptions in 2021. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2021 | 30 | None | 0% (0) | 0% | $608 |
| 2020 | 67 | None | 0% (0) | None | $20,496 |
| 2019 | 53 | None | 0% (0) | None | $50,452 |
| 2015 | 19 | None | 0% (0) | 0% | $2,082 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 3 drugs
| Bupropion Xl | 11 | $361 | $33 |
| Buspirone | 11 | $99 | $9 |
| Lorazepam | 14 | $63 | $4 |
2019: 1 drug
| Lorazepam | 19 | $164 | $9 |
Money from drug and device companies
$45 in 2024
| 2024 | 1 | 1 | None | $45 |
| 2023 | 1 | 1 | $2,160 | $2,160 |
| 2022 | 1 | 1 | $3,430 | $3,430 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Otsuka Pharmaceutical Development & Commercialization | Rejoyn | $45 | 1 payment
|
See the published payment
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2024-08-01 | Rejoyn | $45 |
See earlier years (2023, 2022)
2023: $2,160
| Otsuka Pharmaceutical Development & Commercialization | None | $2,160 | 1 payment
|
2022: $3,430
| Otsuka Pharmaceutical Development & Commercialization | None | $3,430 | 1 payment
|
Professional record
- NPI
- 1952749418
- Licence
- CA A134117California A134117: Current · expires 2027-01-31
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2013-06-06
- NPI last updated
- 2024-04-28
- NPI record certified
- 2024-04-28
This is when the NPI record was last certified, not a medical board exam.